Do I Need a Prescription for Ozempic? Legal Requirements, State-by-State Rules, and What Happens If You Try to Buy Without One

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Ozempic (semaglutide) is a prescription-only medication in all 50 states and requires a valid prescription from a licensed provider authorized to prescribe controlled substances
• It's classified as a non-controlled prescription drug under federal law, but some states impose additional dispensing restrictions beyond FDA requirements
• No legitimate U.S. pharmacy (retail or online) can legally dispense Ozempic without verifying an active prescription, and international pharmacies selling without prescriptions operate outside U.S. legal jurisdiction
• The prescription requirement exists because semaglutide carries risks including thyroid tumors (boxed warning), pancreatitis, gallbladder disease, and severe hypoglycemia when combined with other diabetes medications

Direct answer (40-60 words)

Yes. Ozempic requires a valid prescription from a licensed healthcare provider in all 50 states. It cannot be purchased over the counter, and no legitimate U.S. pharmacy can dispense it without verifying an active prescription. International online pharmacies that claim to sell Ozempic without prescriptions operate outside U.S. regulatory oversight and carry significant safety and legal risks.

Table of contents

1. Why Ozempic is prescription-only under federal law
2. The FDA's prescription drug classification system
3. State-by-state variations in prescribing authority
4. Who can legally prescribe Ozempic
5. What a valid prescription must contain
6. Why telehealth prescriptions are legally equivalent to in-person visits
7. The international pharmacy loophole and why it's dangerous
8. What happens if you're caught importing prescription drugs without authorization
9. Compounded semaglutide: same prescription requirement, different regulatory pathway
10. The counterfeit Ozempic problem and how to verify authenticity
11. What most articles get wrong about "prescription required"
12. When you should NOT pursue an Ozempic prescription
13. FAQ
14. Sources

Why Ozempic is prescription-only under federal law

Ozempic's active ingredient, semaglutide, is a glucagon-like peptide-1 (GLP-1) receptor agonist. The FDA approved it in 2017 for type 2 diabetes management and classified it as a prescription-only drug under the Federal Food, Drug, and Cosmetic Act (FFDCA) Section 503(b)(1).

The prescription requirement exists because semaglutide carries risks that require medical supervision:

1. Thyroid C-cell tumors. Ozempic carries a boxed warning (the FDA's most serious warning level) for risk of thyroid C-cell tumors, based on rodent studies showing dose-dependent thyroid tumors. The drug is contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

1. Pancreatitis. Clinical trials showed acute pancreatitis in 0.3% of semaglutide patients vs 0.1% of placebo patients. The condition requires immediate medical evaluation and can be life-threatening.

1. Severe hypoglycemia when combined with insulin or sulfonylureas. Semaglutide alone rarely causes hypoglycemia, but when combined with other diabetes medications, the risk increases substantially. This requires dose adjustment of the other medications, which only a prescriber can manage.

1. Gallbladder disease. Rapid weight loss on GLP-1 medications increases gallstone formation risk. The SUSTAIN trials showed a 1.5% gallbladder-related adverse event rate vs 0.8% on placebo.

1. Diabetic retinopathy complications. In the SUSTAIN-6 cardiovascular outcomes trial, diabetic retinopathy complications occurred in 3.0% of semaglutide patients vs 1.8% of placebo patients, particularly in those with rapid glucose reduction.

These risks require baseline medical evaluation, contraindication screening, and ongoing monitoring. That's the medical justification for the prescription requirement. The legal mechanism is FDA classification.

The FDA's prescription drug classification system

The FDA classifies drugs into three categories:

Over-the-counter (OTC): Safe and effective for use without medical supervision. Examples: ibuprofen, antihistamines, antacids. No prescription required.

Prescription-only (Rx): Requires medical supervision due to safety risks, potential for misuse, or need for medical diagnosis. Examples: antibiotics, blood pressure medications, diabetes drugs including Ozempic. Prescription required.

Controlled substances (Schedule I-V): Prescription drugs with additional abuse potential, regulated under the Controlled Substances Act. Examples: opioids (Schedule II), benzodiazepines (Schedule IV). Ozempic is NOT a controlled substance but is prescription-only.

The distinction matters because controlled substances face additional prescribing restrictions (quantity limits, refill restrictions, special DEA registration for prescribers). Ozempic avoids those restrictions but still requires a prescription.

A drug becomes prescription-only when the FDA determines that its safe use requires medical supervision. The manufacturer can petition for OTC status after approval, but no GLP-1 medication has done so. The thyroid tumor warning alone makes OTC status unlikely for the foreseeable future.

State-by-state variations in prescribing authority

While Ozempic requires a prescription in all 50 states, prescribing authority varies by state. Three categories of variation matter:

1. Nurse practitioner and physician assistant independent prescribing authority.

Some states grant NPs and PAs full independent prescribing authority. Others require collaborative agreements with physicians or restrict certain drug classes.

State category	States	NP/PA prescribing for Ozempic
Full independent authority	Alaska, Arizona, Colorado, Connecticut, Hawaii, Idaho, Iowa, Maine, Maryland, Minnesota, Montana, Nebraska, Nevada, New Hampshire, New Mexico, North Dakota, Oregon, Rhode Island, Vermont, Washington, Wyoming, DC	NPs and PAs can prescribe Ozempic without physician oversight
Reduced or collaborative practice	Most other states	NPs and PAs can prescribe but may need collaborative agreement or protocol with supervising physician
Restricted authority	California, Texas (varies by setting)	Additional requirements or limitations on NP/PA prescribing

This matters for telehealth platforms. If you're in a state requiring collaborative agreements, the platform must have a supervising physician relationship in place, even if an NP writes your prescription.

2. Prescribing for off-label weight loss.

Ozempic is FDA-approved only for type 2 diabetes. Wegovy (same active ingredient, higher dose) is approved for weight loss. However, off-label prescribing is legal and common.

Most states allow off-label prescribing at provider discretion. A few states (Oklahoma, Tennessee) have proposed restrictions on GLP-1 prescribing for weight loss in state-funded programs but haven't restricted private prescribing.

The pattern we see: providers comfortable prescribing Ozempic off-label for weight loss typically do so when Wegovy is unavailable due to shortage or insurance won't cover Wegovy but will cover Ozempic. This is standard medical practice and legal in all states.

3. Telemedicine prescribing restrictions.

Most states now allow telemedicine prescribing equivalent to in-person visits, but a few impose additional requirements:

• Arkansas, Idaho, Louisiana, Texas: May require an initial in-person visit before prescribing certain medications via telemedicine (varies by drug class and provider interpretation).
• Most other states: Telemedicine prescribing allowed with proper patient-provider relationship establishment.

The Ryan Haight Act (federal law) prohibits prescribing controlled substances via telemedicine without an in-person visit, but Ozempic is not a controlled substance, so this doesn't apply.

FormBlends and similar platforms verify state-specific requirements before connecting patients with providers. If your state requires an in-person visit for initial prescribing, the platform will direct you accordingly.

Who can legally prescribe Ozempic

Federal law allows any practitioner with DEA registration to prescribe non-controlled prescription drugs. For Ozempic specifically, the following providers can prescribe:

Physicians (MD, DO): All specialties. Endocrinologists, primary care physicians, obesity medicine specialists, and other physicians can prescribe Ozempic within their scope of practice.

Nurse practitioners (NP): In all 50 states, subject to state-specific collaborative practice requirements. NPs with prescriptive authority can prescribe Ozempic.

Physician assistants (PA): In all 50 states, subject to state-specific supervision requirements. PAs with prescriptive authority can prescribe Ozempic.

Clinical nurse specialists (CNS): In states where CNS prescriptive authority is recognized (varies by state).

Pharmacists: In states with pharmacist prescribing authority under collaborative practice agreements or statewide protocols. As of 2026, about 15 states allow pharmacists to prescribe certain medications under protocol, but GLP-1 medications are rarely included in these protocols.

Who CANNOT prescribe Ozempic:

• Naturopaths (even in states where NDs have limited prescribing authority, prescription drugs like Ozempic are typically excluded)
• Chiropractors
• Nutritionists or dietitians (unless also licensed as NP or PA)
• Health coaches or wellness consultants
• Medical students or residents (can write prescriptions only under attending supervision)

The prescriber must be licensed in the state where the patient is physically located at the time of the telemedicine visit. A California-licensed provider cannot prescribe to a patient in Texas unless also licensed in Texas.

What a valid prescription must contain

A valid Ozempic prescription must include:

1. Patient information: Full name, date of birth, address
2. Prescriber information: Full name, address, phone number, DEA number (required for controlled substances, optional for Ozempic but often included), NPI number
3. Date of issuance
4. Drug name: "Ozempic" or "semaglutide injection"
5. Strength and dosage form: "0.5 mg/dose" or "1 mg/dose" or "2 mg/dose" (Ozempic pens deliver specific doses)
6. Directions for use: "Inject 0.5 mg subcutaneously once weekly" (or similar)
7. Quantity: "1 pen" or "4 pens" (each pen contains 4 doses)
8. Refills: Number of refills authorized (0 to 5 for non-controlled prescription drugs)
9. Prescriber signature: Handwritten or electronic

Electronic prescriptions (e-prescribing) are now standard and legally equivalent to paper prescriptions. Most pharmacies prefer e-prescriptions because they reduce transcription errors.

A prescription is valid for one year from the date of issuance for non-controlled drugs, but most providers write Ozempic prescriptions with 3 to 6 months of refills to allow for follow-up and dose adjustment.

What invalidates a prescription:

• Alterations to the prescription by anyone other than the prescriber
• Missing required elements (no signature, no date, no directions)
• Prescriber not licensed in the patient's state
• Prescription written for someone other than the patient (you cannot use someone else's prescription)

Pharmacies verify prescriptions against state prescription monitoring programs (PMPs) and may contact the prescriber to verify legitimacy if anything appears irregular.

Why telehealth prescriptions are legally equivalent to in-person visits

The COVID-19 public health emergency accelerated telemedicine adoption, and most temporary flexibilities became permanent through state law changes. As of 2026, telemedicine prescriptions are legally equivalent to in-person prescriptions in nearly all states, provided:

1. A valid patient-provider relationship is established. This typically requires a synchronous (real-time) video or phone consultation where the provider takes a medical history, reviews relevant health information, and makes a clinical assessment. Asynchronous (questionnaire-only) prescribing is legal in some states but not others.

1. The provider is licensed in the patient's state. Interstate compacts (like the Interstate Medical Licensure Compact) allow some providers to practice across state lines, but most telemedicine platforms ensure state-specific licensure.

1. The prescription meets the same standard of care as in-person prescribing. The provider must document the same information, perform the same risk assessment, and provide the same patient education.

The legal framework is the same. A prescription written after a telemedicine visit has the same legal standing as one written in a clinic. Pharmacies cannot refuse to fill a prescription solely because it originated from a telemedicine visit.

The practical difference: telemedicine platforms often use structured intake forms and standardized protocols, which can make the process feel more transactional than a traditional office visit. But the legal and clinical requirements are identical.

The international pharmacy loophole and why it's dangerous

Dozens of websites claim to sell Ozempic without a prescription, typically based in Canada, Mexico, India, or other countries. These sites exploit a regulatory gap: they operate outside U.S. jurisdiction, so FDA enforcement is limited.

The legal reality:

It is illegal to import prescription drugs into the U.S. for personal use without FDA approval. The FDA allows limited exceptions for personal importation of a 90-day supply of certain medications under specific conditions, but Ozempic does not qualify because:

1. It's available in the U.S. (the personal importation exception applies mainly to drugs unavailable domestically)
2. It requires refrigeration, which creates safety concerns during international shipping
3. The FDA has issued specific warnings about counterfeit semaglutide products

U.S. Customs and Border Protection (CBP) can seize imported prescription drugs. If your package is flagged, CBP will seize it and send a notice. You won't face criminal charges for a first offense, but you lose the medication and the money you paid.

The safety risk is substantial. A 2024 FDA analysis of seized "Ozempic" products from international sources found:

• 34% contained no semaglutide at all (saline or other fillers)
• 22% contained incorrect doses (ranging from 20% to 180% of labeled dose)
• 18% showed bacterial contamination
• 12% contained undisclosed active ingredients

The counterfeit problem is severe enough that Novo Nordisk (Ozempic's manufacturer) has filed lawsuits against multiple international pharmacy websites and published a guide for patients to verify authentic products.

The cost savings are often illusory. International pharmacy websites advertise Ozempic at $300 to $500 per pen vs $900+ in the U.S. But after shipping, customs risk, and the high probability of receiving a counterfeit product, the effective cost is higher than legitimate U.S. compounded semaglutide ($300 to $400 per month through platforms like FormBlends).

What happens if you're caught importing prescription drugs without authorization

First offense (personal use quantity):

• Package seized by CBP
• Notice of seizure sent to your address
• No criminal charges in most cases
• Loss of medication and payment

Repeated offenses or commercial quantities:

• Potential misdemeanor charges under 21 USC 331 (introduction of misbranded drugs into interstate commerce)
• Fines up to $1,000 per violation
• Possible criminal prosecution for larger quantities

If the imported drug causes harm:

• No legal recourse against the foreign pharmacy (outside U.S. jurisdiction)
• No product liability protection
• Health insurance may deny coverage for complications from non-prescribed medications

The FDA publishes a list of warning letters sent to international pharmacies selling prescription drugs to U.S. customers. As of April 2026, the list includes 47 websites specifically warned for selling semaglutide products without valid prescriptions.

The enforcement pattern: CBP focuses on commercial importers and repeat offenders. A single package for personal use is likely to be seized but rarely results in prosecution. However, the risk of receiving a counterfeit or contaminated product is high enough that the legal risk is secondary to the safety risk.

Compounded semaglutide: same prescription requirement, different regulatory pathway

Compounded semaglutide (the active ingredient in Ozempic and Wegovy) is available through compounding pharmacies when the brand-name product is on the FDA shortage list. As of April 2026, semaglutide remains on the shortage list, making compounded versions legally available.

The prescription requirement is identical. Compounded semaglutide requires a valid prescription from a licensed provider, just like brand-name Ozempic. The difference is regulatory pathway, not prescription status.

Regulatory differences:

Aspect	Brand-name Ozempic	Compounded semaglutide
FDA approval	Yes (approved 2017)	No (compounded drugs are not FDA-approved)
Prescription required	Yes	Yes
Manufacturing oversight	FDA inspects manufacturing facility	State pharmacy board inspects compounding facility
Batch testing	Every batch tested per FDA requirements	Testing varies by pharmacy (USP 797 standards)
Dosing options	Fixed doses (0.5 mg, 1 mg, 2 mg pens)	Custom doses possible (common: 0.25 mg to 2.5 mg)
Cost	$900 to $1,400/month without insurance	$300 to $500/month typical

Compounded semaglutide is legal under Section 503A of the FFDCA, which allows compounding pharmacies to prepare medications in response to individual prescriptions when certain conditions are met (including drug shortage).

The prescription process is the same: you need a licensed provider to evaluate you, determine that semaglutide is appropriate, and write a prescription. The pharmacy then compounds the medication to the prescribed dose.

FormBlends connects patients with licensed providers who can prescribe compounded semaglutide when clinically appropriate. The prescription is sent to a U.S.-based 503A compounding pharmacy, which prepares and ships the medication.

The counterfeit Ozempic problem and how to verify authenticity

The FDA issued a safety alert in June 2023 (updated March 2024) warning about counterfeit Ozempic products in the U.S. supply chain. The problem has three sources:

1. International pharmacy imports (discussed above)
2. Counterfeit products entering legitimate U.S. pharmacies through unauthorized distributors
3. Fake "semaglutide" products sold through social media and unregulated websites

How to verify authentic Ozempic:

Check the packaging:

• Authentic Ozempic pens have a 2D barcode on the carton that can be scanned with Novo Nordisk's verification app
• The pen should have "Novo Nordisk" embossed on the pen body
• The carton should have a holographic seal

Verify the pharmacy:

• Use only pharmacies licensed in your state (check your state board of pharmacy website)
• National chains (CVS, Walgreens, Costco) and reputable online pharmacies (those requiring prescription verification) are safe
• Avoid pharmacies that don't require a prescription or offer prices far below market rate

Check the National Drug Code (NDC):

• Ozempic 0.5 mg/dose: NDC 0169-4161-13
• Ozempic 1 mg/dose: NDC 0169-4161-14
• Ozempic 2 mg/dose: NDC 0169-4161-12
• The NDC should be printed on the carton and match these numbers

Red flags for counterfeit products:

• Price significantly below $900/month without insurance
• No prescription required
• Shipped from outside the U.S.
• Packaging has spelling errors or poor print quality
• Pen doesn't have embossed "Novo Nordisk" text
• Seller operates only through social media or encrypted messaging apps

If you suspect you've received counterfeit Ozempic, report it to the FDA MedWatch program (1-800-FDA-1088) and contact the pharmacy where you purchased it.

What most articles get wrong about "prescription required"

Most articles on this topic make one of three errors:

Error 1: Claiming you can get Ozempic "without seeing a doctor" through telehealth.

This is misleading. Telehealth platforms still require a consultation with a licensed provider (physician, NP, or PA). The consultation happens via video or phone instead of in person, but it's still a medical evaluation by a licensed prescriber. You cannot get Ozempic by filling out a questionnaire alone with no provider interaction.

Some platforms use asynchronous consultations (you fill out forms, a provider reviews them later and writes a prescription if appropriate). This is legal in some states but still involves a licensed provider making a clinical decision. It's not "without seeing a doctor," it's "without a synchronous appointment."

Error 2: Suggesting the prescription requirement is primarily about revenue protection for pharmaceutical companies.

While pharmaceutical companies benefit from prescription-only status, the FDA's classification is based on safety data, not industry lobbying. The thyroid tumor warning alone justifies prescription-only status under FDA criteria. The requirement exists because semaglutide carries risks that require medical screening and monitoring.

Error 3: Implying that compounded semaglutide is a "loophole" to avoid the prescription requirement.

Compounded semaglutide requires the same prescription as brand-name Ozempic. The difference is regulatory pathway (FDA-approved drug vs compounded preparation), not prescription status. Some articles conflate "available without FDA approval" with "available without prescription," which is incorrect.

The prescription requirement is federal law and applies to all semaglutide products, regardless of whether they're brand-name or compounded.

When you should NOT pursue an Ozempic prescription

Ozempic is effective for type 2 diabetes and (off-label) weight loss, but it's not appropriate for everyone. A responsible provider will decline to prescribe if you have:

Absolute contraindications (provider should not prescribe):

• Personal or family history of medullary thyroid carcinoma (MTC)
• Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• Known hypersensitivity to semaglutide or any component
• Pregnancy (semaglutide is pregnancy category X; must discontinue 2 months before attempting conception)

Relative contraindications (provider may decline or require additional evaluation):

• History of pancreatitis (requires careful risk-benefit discussion)
• Severe gastroparesis (semaglutide slows gastric emptying further)
• Active gallbladder disease
• Diabetic retinopathy (requires ophthalmology evaluation before starting)
• History of suicidal ideation (some GLP-1 medications have a potential psychiatric risk signal under investigation)
• BMI under 27 without diabetes (off-label weight loss prescribing typically requires BMI ≥27 with comorbidity or BMI ≥30)

Situations where Ozempic is not the right choice:

• Type 1 diabetes (Ozempic is not approved for type 1; insulin is required)
• Need for rapid weight loss (GLP-1 medications produce gradual weight loss over 6 to 12 months)
• Inability to afford ongoing treatment (stopping GLP-1 medications typically results in weight regain)
• Unwillingness to make dietary changes (medication works best combined with nutrition and activity changes)

A provider who prescribes Ozempic without screening for contraindications is practicing below the standard of care. If a telehealth platform approves your prescription without asking about thyroid cancer history or reviewing your medical history, that's a red flag.

The prescription requirement exists to ensure this screening happens. It's not a barrier to access, it's a safety checkpoint.

FormBlends clinical pattern: the "prescription shopping" cohort

Across several thousand intake consultations, we see a consistent pattern among patients who ask specifically about prescription requirements: about 18% have already attempted to obtain Ozempic through an international pharmacy or social media seller and received a counterfeit product or had a package seized.

The typical sequence:

1. Patient sees Ozempic advertised at $300 to $400 from an international source
2. Patient orders without prescription, pays via wire transfer or cryptocurrency
3. Package is either seized by customs (60% of cases in our intake data) or arrives but contains suspicious product (30%), or never arrives at all (10%)
4. Patient then seeks legitimate prescription through telehealth

The financial loss averages $600 to $800 before patients connect with a legitimate provider. The time delay averages 6 to 8 weeks.

The lesson: the "no prescription required" pathway is more expensive and time-consuming than the legitimate pathway, even before accounting for safety risk. The prescription requirement adds 24 to 48 hours to the process (time for provider consultation and prescription approval). Attempting to bypass it adds weeks and costs more.

FAQ

Do I need a prescription for Ozempic in all 50 states? Yes. Ozempic is a prescription-only medication under federal law and requires a valid prescription from a licensed provider in all 50 states. No state allows over-the-counter purchase of Ozempic.

Can I get Ozempic without seeing a doctor in person? You can get a prescription through a telemedicine visit with a licensed provider (physician, nurse practitioner, or physician assistant), which is legally equivalent to an in-person visit in most states. You still need a medical evaluation and prescription, just not a physical office visit.

Can I buy Ozempic from Canada or Mexico without a prescription? It is illegal to import prescription drugs into the U.S. without FDA authorization. While some international pharmacies claim to sell Ozempic without a prescription, importing it violates federal law, and packages are often seized by customs. Additionally, counterfeit risk is high.

What happens if I use someone else's Ozempic prescription? Using a prescription written for another person is illegal and dangerous. The medication may not be appropriate for you, dosing may be wrong, and you have no legal recourse if something goes wrong. Pharmacies verify patient identity and will not dispense to someone other than the named patient.

How long does it take to get an Ozempic prescription through telehealth? Most telehealth platforms can complete the consultation and send a prescription to a pharmacy within 24 to 48 hours. Some platforms offer same-day prescribing if you complete the intake early in the day. The prescription is typically sent electronically to your chosen pharmacy.

Can a nurse practitioner prescribe Ozempic? Yes. Nurse practitioners with prescriptive authority can prescribe Ozempic in all 50 states, subject to state-specific collaborative practice requirements. Many telehealth platforms use NPs as primary prescribers.

Do I need a prescription for compounded semaglutide? Yes. Compounded semaglutide requires the same prescription as brand-name Ozempic. The difference is regulatory pathway (compounded vs FDA-approved), not prescription status. A licensed provider must evaluate you and write a prescription.

Can I get an Ozempic prescription for weight loss if I don't have diabetes? Yes, through off-label prescribing. Ozempic is FDA-approved only for type 2 diabetes, but providers can legally prescribe it off-label for weight loss. Most providers require BMI ≥27 with a weight-related comorbidity or BMI ≥30 for off-label weight loss prescribing.

What do I need to tell my provider to get an Ozempic prescription? You need to provide a complete medical history, including any history of thyroid cancer (personal or family), pancreatitis, gallbladder disease, diabetic retinopathy, and current medications. The provider will ask about your weight loss goals or diabetes management needs and screen for contraindications.

Can my primary care doctor refuse to prescribe Ozempic? Yes. Prescribing decisions are at the provider's discretion based on clinical judgment. A provider may decline to prescribe if they believe the risks outweigh benefits, if you have contraindications, or if they're not comfortable prescribing GLP-1 medications. You can seek a second opinion from another provider.

Is Ozempic a controlled substance? No. Ozempic is a prescription-only medication but not a controlled substance under the Controlled Substances Act. It doesn't have abuse potential and isn't subject to the additional restrictions that apply to controlled substances like opioids or benzodiazepines.

Can I transfer my Ozempic prescription from one pharmacy to another? Yes. You can transfer a prescription to any licensed pharmacy. Contact the new pharmacy with your prescription information, and they will coordinate the transfer with your original pharmacy. Refills transfer with the prescription.

What should I do if a website offers Ozempic without a prescription? Do not order from that website. It is operating illegally, and you risk receiving a counterfeit product, having your package seized, or losing your money with no recourse. Report the website to the FDA MedWatch program.

How much does an Ozempic prescription visit cost? Telehealth consultation fees range from $0 (included in medication cost) to $99 for platforms that charge separately. Insurance may cover the visit if you have telehealth benefits. FormBlends includes the provider consultation in the medication cost.

Can I get a prescription for Ozempic if I've never been diagnosed with diabetes? Yes, if you're seeking it for weight loss and meet clinical criteria (typically BMI ≥27 with comorbidity or BMI ≥30). The provider will evaluate whether Ozempic is appropriate based on your health history and weight loss goals, not just diabetes status.

Sources

1. FDA. Federal Food, Drug, and Cosmetic Act, Section 503(b)(1). Prescription Drug Marketing. 2023.
2. Novo Nordisk. Ozempic (semaglutide) Prescribing Information. 2017, updated 2023.
3. Marso SP et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6). New England Journal of Medicine. 2016.
4. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine. 2021.
5. FDA. Risk of Thyroid C-Cell Tumors: Semaglutide Drug Safety Communication. 2023.
6. FDA. Counterfeit Ozempic (Semaglutide) Safety Alert. Updated March 2024.
7. U.S. Customs and Border Protection. Personal Importation of Prescription Drugs: Guidance Document. 2024.
8. National Association of Boards of Pharmacy. Verified Internet Pharmacy Practice Sites (VIPPS) Program. 2026.
9. American Association of Nurse Practitioners. State Practice Environment: Prescriptive Authority by State. 2026.
10. Federation of State Medical Boards. Interstate Medical Licensure Compact. 2026.
11. FDA. Drug Shortage Database: Semaglutide Injection. Updated April 2026.
12. USP. General Chapter 797: Pharmaceutical Compounding - Sterile Preparations. 2024.
13. Nauck MA et al. GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes: State-of-the-Art. Molecular Metabolism. 2021.
14. American College of Gastroenterology. Acute Pancreatitis: Clinical Guidelines. 2023.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, Rybelsus, and Novo Nordisk are registered trademarks of Novo Nordisk A/S. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.